Sientra reported 10.59M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US $ 204.26M 3.14M
Align Technology ALGN:US $ 755.16M 3.38M
Cerus CERS:US $ 24.52M 2.08M
Cooper Companies COO:US $ 501.9M 14.2M
Dexcom DXCM:US $ 446.9M 29.8M
Globus Medical GMED:US $ 171.17M 16M
Insulet PODD:US $ 188.7M 6M
Integra Lifesciences IART:US $ 248.25M 1.2M
Johnson & Johnson JNJ:US $ 16088M 343M
Nuvasive NUVA:US $ 182.18M 34.36M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Rockwell Medical RMTI:US $ -0.33M 0.07M
Sientra SIEN:US 10.59M 675K
Staar Surgical STAA:US $ 45.3M 3.9M
Stryker SYK:US $ 2757M 45M
Teleflex TFX:US $ 387.79M 9.77M
Zimmer Biomet Holdings Inc ZBH:US $ 1.34B 102.8M